Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects
Open Access
- 1 September 2009
- journal article
- review article
- Published by Cambridge University Press (CUP) in Expert Reviews in Molecular Medicine
- Vol. 11, e28
- https://doi.org/10.1017/s1462399409001203
Abstract
Sarcoglycanopathies are a group of autosomal recessive muscle-wasting disorders caused by genetic defects in one of four cell membrane glycoproteins, α-, β-, γ- or δ-sarcoglycan. These four sarcoglycans form a subcomplex that is closely linked to the major dystrophin-associated protein complex, which is essential for membrane integrity during muscle contraction and provides a scaffold for important signalling molecules. Proper assembly, trafficking and targeting of the sarcoglycan complex is of vital importance, and mutations that severely perturb tetramer formation and localisation result in sarcoglycanopathy. Gene defects in one sarcoglycan cause the absence or reduced concentration of the other subunits. Most genetic defects generate mutated proteins that are degraded through the cell's quality control system; however, in many cases, conformational modifications do not affect the function of the protein, yet it is recognised as misfolded and prematurely degraded. Recent evidence shows that misfolded sarcoglycans could be rescued to the cell membrane by assisting their maturation along the ER secretory pathway. This review summarises the etiopathogenesis of sarcoglycanopathies and highlights the quality control machinery as a potential pharmacological target for therapy of these genetic disorders.Keywords
This publication has 131 references indexed in Scilit:
- The concept of translocational regulationThe Journal of cell biology, 2008
- Getting In and Out from Calnexin/Calreticulin CyclesOnline Journal of Public Health Informatics, 2008
- Inhibition of p97-dependent Protein Degradation by Eeyarestatin IOnline Journal of Public Health Informatics, 2008
- PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR -G542X nonsense allele in a CF mouse modelProceedings of the National Academy of Sciences of the United States of America, 2008
- OS-9 and GRP94 deliver mutant α1-antitrypsin to the Hrd1–SEL1L ubiquitin ligase complex for ERADNature, 2008
- Protein quality control in the early secretory pathwayThe EMBO Journal, 2008
- Signal integration in the endoplasmic reticulum unfolded protein responseNature Reviews Molecular Cell Biology, 2007
- ERp57 is essential for efficient folding of glycoproteins sharing common structural domainsThe EMBO Journal, 2006
- Biglycan binds to α‐ and γ‐sarcoglycan and regulates their expression during developmentJournal of Cellular Physiology, 2006
- δ-sarcoglycan is necessary for early heart and muscle development in zebrafishBiochemical and Biophysical Research Communications, 2006